title: Using aptamers for cancer biomarker discovery.
abstract: Aptamers are single-stranded synthetic DNA- or RNA-based oligonucleotides that fold into various shapes to bind to a specific target, which includes proteins, metals, and molecules. Aptamers have high affinity and high specificity that are comparable to that of antibodies. They are obtained using iterative method, called (Systematic Evolution of Ligands by Exponential Enrichment) SELEX and cell-based SELEX (cell-SELEX). Aptamers can be paired with recent advances in nanotechnology, microarray, microfluidics, and other technologies for applications in clinical medicine. One particular area that aptamers can shed a light on is biomarker discovery. Biomarkers are important in diagnosis and treatment of cancer. In this paper, we will describe ways in which aptamers can be used to discover biomarkers for cancer diagnosis and therapeutics.
authors: Center for Research at Bio/Nano Interface, Department of Chemistry and Department of Physiology and Functional Genomics, Shands Cancer Center, UF Genetics Institute and McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
authors: Yun Min
authors: YM
authors: Chang
authors: Michael J
authors: MJ
authors: Donovan
authors: Weihong
authors: W
authors: Tan
references: Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):14087-91
references: 22891333
references: J Proteome Res. 2008 Apr;7(4):1572-83
references: 18290606
references: Anal Chem. 2011 Feb 1;83(3):727-34
references: 21218774
references: Nature. 2012 Oct 4;490(7418):61-70
references: 23000897
references: Mol Oncol. 2012 Apr;6(2):140-6
references: 22356776
references: Science. 2012 Feb 17;335(6070):831-4
references: 22344439
references: PLoS One. 2009 Nov 18;4(11):e7887
references: 19924296
references: Analyst. 2011 Apr 7;136(7):1310-2
references: 21321690
references: Nature. 2012 Jul 18;487(7407):330-7
references: 22810696
references: Nature. 2012 Sep 27;489(7417):519-25
references: 22960745
references: J Neurol Neurosurg Psychiatry. 1994 Oct;57(10):1212-5
references: 7523604
references: Biochim Biophys Acta. 2012 Dec;1826(2):350-6
references: 22683404
references: Clin Cancer Res. 2009 Nov 15;15(22):6980-6
references: 19887487
references: Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):11838-43
references: 16873550
references: J Proteome Res. 2008 May;7(5):2133-9
references: 18363322
references: Cell. 1986 Oct 10;47(1):131-9
references: 2428505
references: Nat Biotechnol. 2003 Mar;21(3):255-61
references: 12610572
references: Nature. 1999 Jul 29;400(6743):464-8
references: 10440377
references: Am J Pathol. 2011 Jul;179(1):116-24
references: 21703397
references: Exp Mol Pathol. 2009 Jun;86(3):151-64
references: 19454272
references: Acc Chem Res. 2010 Jan 19;43(1):48-57
references: 19751057
references: Methods. 2011 Jun;54(2):215-25
references: 21300154
references: Br J Cancer. 2004 Jul 19;91(2):355-8
references: 15188009
references: Br J Cancer. 1996 Oct;74(7):999-1004
references: 8855965
references: Anal Chem. 1999 Nov 1;71(21):742A-748A
references: 10565269
references: Cancer Res. 2010 Nov 1;70(21):8617-29
references: 20861190
references: Drug Discov Today. 2004 Dec 1;9(23):1012-9
references: 15574317
references: PLoS One. 2010 Dec 07;5(12):e15004
references: 21165148
references: J Nucl Med. 2010 Jan;51(1):98-105
references: 20008986
references: Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15416-21
references: 14676325
references: Diabetologia. 2009 Nov;52(11):2445-54
references: 19707743
references: Nat Rev Drug Discov. 2010 Jul;9(7):537-50
references: 20592747
references: Nat Protoc. 2010 Jun;5(6):1169-85
references: 20539292
references: Nat Protoc. 2010 Dec;5(12):1993-2004
references: 21127492
references: Nature. 2008 Oct 23;455(7216):1061-8
references: 18772890
references: PLoS One. 2010 Dec 07;5(12):e15003
references: 21170350
references: Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3410-5
references: 12624183